HighField CEO Talks
Hear Dr. Yuhong Xu, Scientific Founder & CEO of HighField Bio talk, in her own words,
about the science behind HighField’s lipid nanostructures.
No. 1: Initial clinical data analysis of HighField ADCplex – presented at ASCO 2025 Meeting.
No. 2: Report on first patient dosing of HF50, Liposomal T cell engager.
No. 3: Report on first patient dosing of HF50, Liposomal T cell engager.
No. 4: Learn about T cell engaging complexes and Highfield’s new T cell transducing complexes
English 
简体中文